moitessier - Search Results

Year	Number of Results
1998	1
2001	4
2002	3
2004	2
2005	1
2006	2
2007	4
2008	6
2009	5
2010	3
2011	3
2012	4
2013	3
2014	5
2015	6
2016	6
2017	8
2018	6
2019	9
2020	7
2021	3
2022	7
2023	2
2024	3

1

Moitessier N, Nowick J. Moitessier N, et al. Eur J Med Chem. 2022 Jun 5;236:114340. doi: 10.1016/j.ejmech.2022.114340. Epub 2022 Mar 31. Eur J Med Chem. 2022. PMID: 35405398 Free PMC article. No abstract available.

2

Covalent inhibitors design and discovery.

De Cesco S, Kurian J, Dufresne C, Mittermaier AK, Moitessier N. De Cesco S, et al. Eur J Med Chem. 2017 Sep 29;138:96-114. doi: 10.1016/j.ejmech.2017.06.019. Epub 2017 Jun 10. Eur J Med Chem. 2017. PMID: 28651155 Review.

3

Design and discovery of boronic acid drugs.

Plescia J, Moitessier N. Plescia J, et al. Eur J Med Chem. 2020 Jun 1;195:112270. doi: 10.1016/j.ejmech.2020.112270. Epub 2020 Mar 30. Eur J Med Chem. 2020. PMID: 32302879 Review.

4

Editorial: advances in computational structure based drug discovery.

Tóth G, Moitessier N. Tóth G, et al. Curr Pharm Des. 2014;20(20):3265. Curr Pharm Des. 2014. PMID: 24934512 No abstract available.

5

Targeting MYC: From understanding its biology to drug discovery.

Ross J, Miron CE, Plescia J, Laplante P, McBride K, Moitessier N, Möröy T. Ross J, et al. Eur J Med Chem. 2021 Mar 5;213:113137. doi: 10.1016/j.ejmech.2020.113137. Epub 2020 Dec 29. Eur J Med Chem. 2021. PMID: 33460833 Review.

6

Computational and biophysical methods for the discovery and optimization of covalent drugs.

Wang G, Moitessier N, Mittermaier AK. Wang G, et al. Chem Commun (Camb). 2023 Sep 12;59(73):10866-10882. doi: 10.1039/d3cc03285j. Chem Commun (Camb). 2023. PMID: 37609777 Review.

7

Enzyme Kinetics by Isothermal Titration Calorimetry: Allostery, Inhibition, and Dynamics.

Wang Y, Wang G, Moitessier N, Mittermaier AK. Wang Y, et al. Front Mol Biosci. 2020 Oct 19;7:583826. doi: 10.3389/fmolb.2020.583826. eCollection 2020. Front Mol Biosci. 2020. PMID: 33195429 Free PMC article. Review.

8

Challenges and current status of computational methods for docking small molecules to nucleic acids.

Luo J, Wei W, Waldispühl J, Moitessier N. Luo J, et al. Eur J Med Chem. 2019 Apr 15;168:414-425. doi: 10.1016/j.ejmech.2019.02.046. Epub 2019 Feb 15. Eur J Med Chem. 2019. PMID: 30831409 Review.

9

Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.

Lawandi J, Gerber-Lemaire S, Juillerat-Jeanneret L, Moitessier N. Lawandi J, et al. J Med Chem. 2010 May 13;53(9):3423-38. doi: 10.1021/jm901104g. J Med Chem. 2010. PMID: 20058865 Review. No abstract available.

10

Discovery of novel small-molecule antagonists for GluK2.

Schiavini P, Dawe GB, Bowie D, Moitessier N. Schiavini P, et al. Bioorg Med Chem Lett. 2015 Jun 1;25(11):2416-20. doi: 10.1016/j.bmcl.2015.04.008. Epub 2015 Apr 10. Bioorg Med Chem Lett. 2015. PMID: 25913117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year